1h Free Analyst Time
In-depth Analysis on Market Size, Share, & Trends Analysis Report by Product Type, Application, End-user and Geography are included in this Global Bone Growth Products Market Report Speak directly to the analyst to clarify any post sales queries you may have.
The bone growth products market by revenue is expected to grow at a CAGR of over 3.60% during the period 2022-2027.
GLOBAL BONE GROWTH PRODUCTS MARKET SEGMENTATION
The bone growth stimulator devices segment dominates the global bone growth products market, accounting for a share of 51.12%, followed by bone morphogenetic protein with 39.15% in 2021.
Based on end-users, the market is segmented into hospitals & clinics, specialty orthopedic and spine centers, and ASCs. Hospitals & clinics segment is dominating in the market whereas, specialty orthopedic & spine centers is growing at 4.47% CAGR as patients increasingly prefer specialty spine care centers over multi-specialty hospitals.
Market Segmentation by Product Type
- Bone Growth Stimulator Device
- Bone Morphogenic Protein
- Platelet Rich Plasma
Market Segmentation by Application
- Spinal Fusion Surgeries
- Oral and Maxillofacial Surgeries
- Delayed Union and Non-Union Bone Fracture
- Others
Market Segmentation by Application
- Hospitals and Clinic
- Specialty Orthopaedic and Spine Center
- Ambulatory Surgery Centers
VENDOR ANALYSIS
Global players in the market are adopting acquisition strategies to remain competitive and extend their presence across geographies for higher market share. In addition, the competition among tier II and III players is high, with many regional and local players offering a diverse range of bone growth products.
PROMINENT VENDORS
- Bioventus
- DJO
- Johnson & Johnson
- Medtronic
- Orthofix Medical
- Stryker
- Zimmer Biomet
OTHER PROMINENT VENDORS
- BTT Health
- Elizur
- Fintek Bio-Electric
- Isto Biologics
- ITO
- Kinex Medical Company
- Ossatec Benelux
- Osteotec
- Paragon 28
- Royal Biologics
- Stimulate Health
- Smith+Nephew
- SpineVision
- VQ OrthoCare
GEOGRAPHICAL ANALYSIS
In 2021, North America accounted for a revenue share of 41.45% in the global bone growth products market. The regional market is expected to retain its dominance during the forecast period and is likely to grow at a lesser CAGR than APAC as it has reached maturity.
Market Segmentation by Geography
- North America
- US
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- UK
- APAC
- China
- Japan
- India
- Australia
- South Korea
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East and Africa
- South Africa
- Saudi Arabia
- Turkey
THE REPORT INCLUDES:
1. The analysis of the global Bone Growth Products market provides market size and growth rate for the forecast period 2022-2027.
2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the global Bone Growth Products market.
3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
4. It offers a complete overview of market segments and the regional outlook of the global Bone Growth Products market.
5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.
Table of Contents
1 Research Methodology2 Research Objectives3 Research Process6 Market at a Glance
4 Scope & Coverage
5 Report Assumptions & Caveats
7 Introduction
8 Market Opportunities & Trends
9 Market Growth Enablers
10 Market Growth Restraints
11 Market Landscape
12 Product Analysis
13 Application Segmentation
14 End-User Analysis
15 Geographic Insights
16 North America
17 Europe
18 Apac
19 Latin America
20 Middle East & Africa
21 Competitive Landscape
22 Key Company Profiles
23 Other Prominent Vendors
24 Report Summary
25 Quantitative Summary
26 Appendix
Companies Mentioned
- Bioventus
- DJO
- Johnson & Johnson
- Medtronic
- Orthofix Medical
- Stryker
- Zimmer Biomet
- BTT Health
- Elizur
- Fintek Bio-Electric
- Isto Biologics
- ITO
- Kinex Medical Company
- Ossatec Benelux
- Osteotec
- Paragon 28
- Royal Bio
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 317 |
| Published | March 2022 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value ( USD | $ 1178 Million |
| Forecasted Market Value ( USD | $ 1456.43 Million |
| Compound Annual Growth Rate | 3.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
